切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (02) : 138 -141. doi: 10.3877/cma.j.issn.1673-5250.2021.02.003

所属专题: 文献

专题论坛

子宫内膜异位症发病机制的研究现状
梁梦珊, 朱耀魁()   
  • 收稿日期:2021-01-09 修回日期:2021-03-07 出版日期:2021-04-01
  • 通信作者: 朱耀魁

Current research status on pathogenesis of endometriosis

Mengshan Liang, Yaokui Zhu()   

  • Received:2021-01-09 Revised:2021-03-07 Published:2021-04-01
  • Corresponding author: Yaokui Zhu
  • Supported by:
    Natural Science Foundation of Guangdong Province(10151063201000058); Research Foundation of Medical Science and Technology of Guangdong Province(A2011344)
引用本文:

梁梦珊, 朱耀魁. 子宫内膜异位症发病机制的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2021, 17(02): 138-141.

Mengshan Liang, Yaokui Zhu. Current research status on pathogenesis of endometriosis[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(02): 138-141.

子宫内膜异位症(EMS)是一种具有恶性行为的良性疾病,关于其发病机制则迄今尚未完全阐明。子宫内膜异位病灶可能由子宫内膜间充质干细胞(eMSC)或骨髓来源干细胞群(bMSC)转移、种植、分化而来,同时免疫细胞分泌多种炎症介质,可引发炎症级联反应,为EMS患者子宫内膜组织生长、侵袭提供局部微环境。笔者拟就干细胞、免疫细胞等在EMS发病机制中作用的研究现状进行阐述。

Endometriosis (EMS)is a benign disease with malignant behavior, and its pathogenesis has not been explained completely and clearly so far. Latest studies have found that the occurence and development of EMS can be accounted for transfer, implantation and differentiation of endometrial mesenchymal stem cells (eMSC) or bone marrow stem cells (bMSC). At the same time, inflammatory cascade reaction caused by secretion of a variety of inflammatory mediators by immune cells provides a local microenvironment for growth and invasion of endometrium ectopic tissue. In this paper, research progresses on EMS pathogenesis are summarized based on stem cells and immune cells.

[1]
Horne AW, Saunders PTK. Snap shot: endometriosis[J]. Cell, 2019, 179(7): 1677-1677. DOI: 10.1016/j.cell.2019.11.033.
[2]
郎景和,崔恒,戴毅,等.2015年子宫内膜异位症的诊治指南专家解读[J]. 中华妇产科杂志,2017,52(12): 857-861. DOI: 10.3760/cma.j.issn.0529-567x.2017.12.013.
[3]
Cousins FL, O DF, Gargett CE. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis[J]. Best Pract Res Clin Obstet Gynaecol, 2018, 20: 27-38. DOI: 10.1016/j.bpobgyn.2018.01.011.
[4]
Xu S, Chan RWS, Ng EHY, et al. Spatial and temporal characterization of endometrial mesenchymal stem-like cells activity during the menstrual cycle[J]. Exp Cell Res, 2017, 350(1): 184-189. DOI: 10.1016/j.yexcr.2016.11.020.
[5]
Barragan F, Irwin JC, Balayan S, et al. Human endometrial fibroblasts derived from mesenchymal progenitors inherit progesterone resistance and acquire an inflammatory phenotype in the endometrial niche in endometriosis[J]. Biol Reprod, 2016, 94(5): 118. DOI: 10.1095/biolreprod.115.136010.
[6]
Baranov VS, Ivaschenko TE, Yarmolinskaya MI. Comparative systems genetics view of endometriosis and uterine leiomyoma: two sides of the same coin?[J].Syst Biol Reprod Med, 2016, 62(2): 93-105.DOI: 10.3109/19396368.2015.1123325.
[7]
Guo SW. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology[J]. Hum Reprod Update, 2020, 26(3): 423-449.DOI: 10.1093/humupd/dmz047.
[8]
Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis[J]. Endocr Rev, 2019, 40(4): 1048-1079.DOI: 10.1210/er.2018-00242.
[9]
Wang LX, Zhao J, Li Y, et al. Genome-wide analysis of DNA methylation in endometriosis using illumina human methylation 450 K bead chips[J]. Mol Reprod Dev, 2019, 86(5): 491-501. DOI: 10.1002/mrd.23127.
[10]
Tampaki EC, Tampakis A, Kontzoglou K, et al. Commentary: somatic stem cells and their dysfunction in endometriosis[J]. Front Surg, 2017, 4: 37.DOI: 10.3389/fsurg.2017.00037.
[11]
Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility[J]. Obstet Gynecol Clin North Am, 2012, 39(4): 535-549. DOI: 10.1016/j.ogc.2012.10.002.
[12]
Li F, Alderman MH, Tal A, et al. Hematogenous dissemination of mesenchymal stem cells from endometriosis[J]. Stem Cells, 2018, 36(6): 881-890. DOI: 10.1002/stem.2804.
[13]
Koninckx PR, Ussia A, Adamyan L, et al. Pathogenesis of endometriosis: the genetic/epigenetic theory[J]. Fertil Steril, 2019, 111(2): 327-340. DOI: 10.1016/j.fertnstert.2018.10.013.
[14]
O DF, Roskams T, Van den Eynde K, et al. The presence of endometrial cells in peritoneal fluid of women with and without endometriosis[J]. Reprod Sci, 2017, 24(2): 242-251. DOI: 10.1177/1933719116653677.
[15]
Chen P, Mamillapalli R, Habata S, et al. Endometriosis cell proliferation induced by bone marrow mesenchymal stem cells[J]. Reprod Sci, 2021, 28(2): 426-434. DOI: 10.1007/s43032-020-00294-4.
[16]
Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis[J]. Stem Cells, 2007, 25(8): 2082-2086. DOI: 10.1634/stemcells.2006-0828.
[17]
Zondervan KT, Becker CM, Koga K, et al. Endometriosis[J].Nat Rev Dis Primers, 2018, 4(1): 9. DOI: 10.1038/s41572-018-0008-5.
[18]
Moridid I, Mamillapalli R, Cosar E, et al. Bone marrow stem cell chemotactic activity is induced by elevated CXCL12 in endometriosis[J]. Roprod Sci, 2016, 24(4):526-533.DOI: 10.1177/1933719116672587.
[19]
AlAshqar A, Reschke L, Kirschen GW, et al. Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies[J]. Biol Reprod, 2021: ioab054.DOI: 10.1093/biolre/ioab054.
[21]
Ahn SH, Khalaj K, Young SL, et al. Immune-inflammation gene signatures in endometriosis patients[J].Fertil Steril, 2016, 106(6): 1420-1431.e7. DOI: 10.1016/j.fertnstert.2016.07.005.
[22]
Chen Y, Wang K, Xu Y, et al. Alteration of myeloid-derived suppressor cells, chronic inflammatory cytokines, and exosomal miRNA contribute to the peritoneal immune disorder of patients with endometriosis[J].Reprod Sci, 2019, 26(8): 1130-1138. DOI: 10.1177/1933719118808923.
[23]
Aksak T, Gümürdülü D, Cetin MT, et al. Expression of monocyte chemotactic protein 2 and tumor necrosis factor alpha in human normal endometrium and endometriotic tissues[J].J Gynecol Obstet Hum Reprod, 2021, 50(5): 101971. DOI: 10.1016/j.jogoh.2020.101971.
[24]
Guo SW, Du YB, Liu X. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis[J]. Hum Reprod, 2016, 31(7): 1462-1474. DOI: 10.1093/humrep/dew057.
[25]
Yu JJ, Sun HT, Zhang ZF, et al. IL15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis[J]. Reproduction, 2016, 152(2): 151-160. DOI: 10.1530/REP-16-0089.
[26]
Yang HL, Zhou WJ, Chang KK, et al. The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-beta[J]. Reproduction, 2017, 154(6): 815-825. DOI: 10.1530/REP-17-0342.
[27]
王卡娜,郄明蓉. 辅助性T细胞17及调节性T细胞比例失衡与子宫内膜异位症研究现状[J/CD]. 中华妇幼临床医学杂志(电子版),2019,15 (1): 2-7. DOI: 10.3877/cma.j.issn.1673-5250.2019.01.001.
[28]
Shan J, Ni Z, Cheng W, et al. Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis[J]. Arch Gynecol Obstet, 2021. DOI: 10.1007/s00404-021-06057-z..
[29]
Hou XX, Wang XQ, Zhou WJ, et al. Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu[J]. Commun Biol, 2021, 4(1): 499. DOI: 10.1038/s42003-021-02018-z.
[1] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[2] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[3] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[4] 宋勤琴, 李双汝, 李林, 杜鹃, 刘继松. 间充质干细胞源性外泌体在改善病理性瘢痕中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 550-553.
[5] 刘昌玲, 张金丽, 张志, 李孝建, 汤文彬, 胡逸萍, 陈宾, 谢晓娜. 负载人脂肪干细胞外泌体的甲基丙烯酰化明胶水凝胶对人皮肤成纤维细胞增殖和迁移的影响[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 517-525.
[6] 雷子威, 凌萍, 沈纵, 魏晨如, 朱邦晖, 伍国胜, 孙瑜. 类器官肺损伤疾病模型构建及应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 531-535.
[7] 胡启明, 鄢潇, 尤志学, 黄骁昊. 经瘢痕处单孔腹腔镜下切除多病灶腹壁子宫内膜异位症[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 314-317.
[8] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[9] 王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[10] 刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[11] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[12] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[13] 芦煜, 李振宇, 吴承东, 周仲伍. 肛周子宫内膜异位症一例报告[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 431-434.
[14] 杨卫东, 周威, 向洪涛. 慢性萎缩性胃炎患者幽门螺杆菌感染与炎性细胞因子及病理特征的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 459-464.
[15] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?